Agarwal R, Chapple P, Brown M, Szer J, Juneja S
Department of Diagnostic, Royal Melbourne Hospital, Parkville, Vic., Australia.
Int J Lab Hematol. 2015 Feb;37(1):14-21. doi: 10.1111/ijlh.12207. Epub 2014 Apr 4.
Flow cytometry is the most sensitive and specific diagnostic modality for the assessment of clone size in paroxysmal nocturnal haemoglobinuria (PNH) and other bone marrow failure states. In this study, we attempt to distinguish PNH from aplastic anaemia (AA) and myelodysplastic syndromes (MDS) associated with PNH clones at diagnosis by clone size, clinical and laboratory features.
A total of 29 samples included 19 PNH cases and 10 AA/MDS cases with PNH clones. Flow cytometry was performed using fluorescent aerolysin (FLAER)-based assay and comparison of clinical features, laboratory parameters and PNH clone size was carried out at diagnosis.
The PNH clone size on granulocytes varied from 0.4% to 99.2% and correlated with the clone size on monocytes (r = 0.966; P < 0.001). Paroxysmal nocturnal haemoglobinuria clone size on granulocytes (median = 34.6%) and monocytes (median = 49.9%) was always larger than erythrocytes (median = 10.9%). The median clone size in PNH (median granulocytes = 74.9%, monocytes = 71.8%) was significantly greater than in AA/MDS associated with PNH clone (median granulocytes = 2.9%, monocytes = 6%). In PNH patients, a significant negative correlation was seen between PNH clone on monocytes and the haemoglobin concentration.
In our small study using the FLAER method, the clone size was >70% in majority of PNH cases. In other marrow disorders like AA/MDS, the clone size was usually <10%.
流式细胞术是评估阵发性睡眠性血红蛋白尿(PNH)及其他骨髓衰竭状态下克隆大小最敏感且特异的诊断方法。在本研究中,我们试图通过克隆大小、临床及实验室特征,在诊断时将PNH与伴有PNH克隆的再生障碍性贫血(AA)和骨髓增生异常综合征(MDS)区分开来。
共29份样本,包括19例PNH病例和10例伴有PNH克隆的AA/MDS病例。采用基于荧光气单胞菌溶素(FLAER)的检测方法进行流式细胞术检测,并在诊断时比较临床特征、实验室参数及PNH克隆大小。
粒细胞上的PNH克隆大小在0.4%至99.2%之间,且与单核细胞上的克隆大小相关(r = 0.966;P < 0.001)。粒细胞(中位数 = 34.6%)和单核细胞(中位数 = 49.9%)上的阵发性睡眠性血红蛋白尿克隆大小总是大于红细胞(中位数 = 10.9%)。PNH中的克隆大小中位数(粒细胞中位数 = 74.9%,单核细胞中位数 = 71.8%)显著大于伴有PNH克隆的AA/MDS(粒细胞中位数 = 2.9%,单核细胞中位数 = 6%)。在PNH患者中,单核细胞上的PNH克隆与血红蛋白浓度之间存在显著负相关。
在我们使用FLAER方法的小型研究中,大多数PNH病例的克隆大小>70%。在其他骨髓疾病如AA/MDS中,克隆大小通常<10%。